Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis.
about
PI3K/AKT/mTOR Pathway in AngiogenesisIntegration of a Notch-dependent mesenchymal gene program and Bmp2-driven cell invasiveness regulates murine cardiac valve formation.The F-BAR protein NOSTRIN participates in FGF signal transduction and vascular development.Eph/ephrin molecules--a hub for signaling and endocytosisNon-SH2/PDZ reverse signaling by ephrinsMarkers of Response to Antiangiogenic Therapies in Colorectal Cancer: Where Are We Now and What Should Be Next?The cellular response to vascular endothelial growth factors requires co-ordinated signal transduction, trafficking and proteolysisEndothelial tip cells in ocular angiogenesis: potential target for anti-angiogenesis therapyMouse models for studying angiogenesis and lymphangiogenesis in cancerMolecular control of endothelial cell behaviour during blood vessel morphogenesisEndothelial expression of TGFβ type II receptor is required to maintain vascular integrity during postnatal development of the central nervous systemNogo-B regulates endothelial sphingolipid homeostasis to control vascular function and blood pressureStability and function of adult vasculature is sustained by Akt/Jagged1 signalling axis in endothelium.Cdc42 and k-Ras Control Endothelial Tubulogenesis through Apical Membrane and Cytoskeletal Polarization: Novel Stimulatory Roles for GTPase Effectors, the Small GTPases, Rac2 and Rap1b, and Inhibitory Influence of Arhgap31 and Rasa1Cartilage-specific deletion of ephrin-B2 in mice results in early developmental defects and an osteoarthritis-like phenotype during aging in vivo.Nestin(+) cells direct inflammatory cell migration in atherosclerosis.Micro-CT Imaging Reveals Mekk3 Heterozygosity Prevents Cerebral Cavernous Malformations in Ccm2-Deficient MiceFbxw7 controls angiogenesis by regulating endothelial Notch activityCdc42 is required for cytoskeletal support of endothelial cell adhesion during blood vessel formation in mice.Excessive vascular sprouting underlies cerebral hemorrhage in mice lacking αVβ8-TGFβ signaling in the brain.VEGF signaling inside vascular endothelial cells and beyond.Gene expression profiling identifies EPHB4 as a potential predictive biomarker in colorectal cancer patients treated with bevacizumab.The short and long of noncoding sequences in the control of vascular cell phenotypesAngiogenesis and liver fibrosisSchlemm's canal is a unique vessel with a combination of blood vascular and lymphatic phenotypes that forms by a novel developmental processNovel strategy for selection of monoclonal antibodies against highly conserved antigens: phage library panning against ephrin-B2 displayed on yeastRab13-dependent trafficking of RhoA is required for directional migration and angiogenesisSpatial regulation of VEGF receptor endocytosis in angiogenesisNotch-dependent VEGFR3 upregulation allows angiogenesis without VEGF-VEGFR2 signallingPkd1 regulates lymphatic vascular morphogenesis during developmentNRP1 acts cell autonomously in endothelium to promote tip cell function during sprouting angiogenesisPEGylation potentiates the effectiveness of an antagonistic peptide that targets the EphB4 receptor with nanomolar affinityEndothelial cell-derived CD95 ligand serves as a chemokine in induction of neutrophil slow rolling and adhesionFlt-1 (VEGFR-1) coordinates discrete stages of blood vessel formationKLF4 is a key determinant in the development and progression of cerebral cavernous malformations.Attenuation of ephrinB2 reverse signaling decreases vascularized area and preretinal vascular tuft formation in the murine model of oxygen-induced retinopathy.Cyclin-dependent kinase 5 regulates endothelial cell migration and angiogenesis.Mechanoinduction of lymph vessel expansion.Perfusable branching microvessel bed for vascularization of engineered tissues.Sox17 is indispensable for acquisition and maintenance of arterial identity
P2860
Q21129332-CC460885-8EF5-45E5-BA5E-EE8E431482E4Q24301606-9C05EB4E-1F24-4965-A86C-8CD91243E19FQ24339432-39DC461F-BD21-4861-8AC2-2AF21EE77B64Q24611588-86E1F636-55E2-4993-A67B-70285A257138Q24629619-D5459A0D-E722-4899-BCA9-4C90A2270F95Q26752752-B7635FFE-5DAE-48D7-99A3-28711D57E733Q26796921-47CE6D75-DF94-4952-9606-86471BEC778BQ26865091-317ADF41-FC58-4E36-B8A3-ADC1CDBC8E44Q27003898-C85692AE-95F9-47A8-9A54-EF77D57BD958Q27007664-216B080B-4DB6-4EC6-A118-BF47222FACBEQ27300866-E09A3A96-E411-49DE-B883-1C22B2338E9EQ27315147-1FF9DDD9-45D0-414F-A071-2927C20EB676Q27324465-6686BAD3-7576-459E-A6F5-0F218B1071EAQ27324682-8EA5C127-C707-4A6A-9335-62399C050B4CQ27325791-374059CF-A995-416C-94AE-B4E214670365Q27329117-EADA9FBC-CC87-462D-89DA-5BF5D9E6855EQ27329910-C0B31CFF-467D-415B-8069-5FDDB72357B8Q27332457-B20A6989-5318-40BE-9FC9-87336C41222EQ27342778-D8FE80DE-31D8-4914-8451-0738BF1BBD23Q27346828-6424FBEA-0AC3-4CE0-BE7B-76380E9072DEQ27687815-43049A92-9575-4173-975D-291E20031579Q27852191-0CFCFCFF-6BB0-410B-99D1-2A731C8B9E24Q28080857-707AF92E-56AA-424A-8052-2577786F54C6Q28082569-673A43D9-B01B-47EE-923C-9D7024B822C7Q28244469-FFA88041-CC67-448E-847F-356BEDFDE195Q28479031-CB4A4FB0-29C0-47FE-B502-6C513FCDDA9EQ28510232-22C1EB92-1BDF-4FE8-BDAA-EC0AFE43CB29Q28585752-40169A90-66D0-4022-A986-A9DC781C456DQ28587298-D798C9C2-11D6-4A5A-AF66-465C82733BECQ28592117-13722D41-DE69-4F68-8E8D-DC502A705446Q28592186-121F2039-42A4-4EDD-BA50-F9A2E9A61A6DQ28741459-EA32E27D-8FE6-405E-BDB2-72508040D6D8Q28821976-493BD0E4-1468-407D-B604-9E09BE19274CQ30276870-B9842CED-CD03-478F-AAF1-279F806EFB90Q30278010-F48816E9-DF5C-4979-B0BD-2535F9BB4124Q30414333-112E4D44-3EDA-4063-8917-FBBFDCA6192DQ30497293-4D5C7228-09C4-44B9-8449-B572E00004FFQ30505376-9B4188B8-5DD9-4504-BBD6-790269334474Q30530486-E0B83573-47C9-4AD7-9F28-4E088F9DE15CQ30557264-73AE88A2-2DAC-4D63-A5BA-9C2F90AFE475
P2860
Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis.
@ast
Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis.
@en
Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis.
@nl
type
label
Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis.
@ast
Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis.
@en
Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis.
@nl
prefLabel
Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis.
@ast
Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis.
@en
Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis.
@nl
P2093
P356
P1433
P1476
Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis.
@en
P2093
Akira Sakakibara
Alcide Barberis
Alice Davy
Catherine D Nobes
Laura E Benjamin
Magdalena L Bochenek
Mara E Pitulescu
Masanori Nakayama
Susanne Adams
Taija Mäkinen
P2888
P304
P356
10.1038/NATURE09002
P407
P50
P577
2010-05-01T00:00:00Z
P5875
P6179
1028883419